Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

J. Chalmers; H. Arima; M. Woodward; G. Mancia; N. Poulter; Y. Hirakawa; S. Zoungas; A. Patel; B. Williams; S. Harrap

doi:10.1161/HYP.0000000000000030

Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

J. Chalmers, H. Arima, M. Woodward, G. Mancia, N. Poulter, Y. Hirakawa, S. Zoungas, A. Patel, B. Williams, S. Harrap

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	e2
Journal	Hypertension
Volume	66
Issue number	1
DOIs	https://doi.org/10.1161/HYP.0000000000000030
Publication status	Published - Jul 4 2015
Externally published	Yes

All Science Journal Classification (ASJC) codes

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/HYP.0000000000000030

Cite this

Chalmers, J., Arima, H., Woodward, M., Mancia, G., Poulter, N., Hirakawa, Y., Zoungas, S., Patel, A., Williams, B., & Harrap, S. (2015). Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). Hypertension, 66(1), e2. https://doi.org/10.1161/HYP.0000000000000030

Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). / Chalmers, J.; Arima, H.; Woodward, M. et al.
In: Hypertension, Vol. 66, No. 1, 04.07.2015, p. e2.

Research output: Contribution to journal › Comment/debate › peer-review

Chalmers, J, Arima, H, Woodward, M, Mancia, G, Poulter, N, Hirakawa, Y, Zoungas, S, Patel, A, Williams, B & Harrap, S 2015, 'Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)', Hypertension, vol. 66, no. 1, pp. e2. https://doi.org/10.1161/HYP.0000000000000030

Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y et al. Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). Hypertension. 2015 Jul 4;66(1):e2. doi: 10.1161/HYP.0000000000000030

Chalmers, J. ; Arima, H. ; Woodward, M. et al. / Erratum : Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252). In: Hypertension. 2015 ; Vol. 66, No. 1. pp. e2.

@article{f27ae2d400e846bca661db323c4fe49e,

title = "Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)",

author = "J. Chalmers and H. Arima and M. Woodward and G. Mancia and N. Poulter and Y. Hirakawa and S. Zoungas and A. Patel and B. Williams and S. Harrap",

year = "2015",

month = jul,

day = "4",

doi = "10.1161/HYP.0000000000000030",

language = "English",

volume = "66",

pages = "e2",

journal = "Hypertension",

issn = "0194-911X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/HYPERTENSIONAHA.113.02252)

AU - Chalmers, J.

AU - Arima, H.

AU - Woodward, M.

AU - Mancia, G.

AU - Poulter, N.

AU - Hirakawa, Y.

AU - Zoungas, S.

AU - Patel, A.

AU - Williams, B.

AU - Harrap, S.

PY - 2015/7/4

Y1 - 2015/7/4

UR - http://www.scopus.com/inward/record.url?scp=84942763923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942763923&partnerID=8YFLogxK

U2 - 10.1161/HYP.0000000000000030

DO - 10.1161/HYP.0000000000000030

M3 - Comment/debate

AN - SCOPUS:84942763923

SN - 0194-911X

VL - 66

SP - e2

JO - Hypertension

JF - Hypertension

IS - 1

ER -

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this